SUMMARY -Premature infants are susceptible to oxidative stress that causes neonatal disease such as retinopathy of prematurity (ROP). Oxidative stress is an imbalance between the production of pro-oxidants and the ability of the body to detoxify their harmful eff ects by antioxidants. Th e proliferative phase 2 ROP occurs at around 33 rd postmenstrual week (pmw). Th e purpose of our study was to evaluate the pro-oxidant/antioxidant status in preterm infants at 33 rd pmw. Th e study included 59 premature infants. ROP was classifi ed according to the International Classifi cation of Retinopathy of Prematurity. Total oxidative status (TOS), total antioxidant status (TAS), malondialdehyde (MDA) and paraoxonase 1 (PON1) activity were determined spectrophotometrically. Th e values of the prooxidants TOS and MDA were signifi cantly higher in infants with ROP as compared to infants without ROP (p<0.05 both). Th ere were no signifi cant diff erences in the values of TAS and PON1 between the infants with and without ROP. According to study results, TOS and MDA are good markers of oxidative stress, whereas TAS and PON1 activity are unreliable in assessing antioxidant protection.
Introduction
Premature infants belong to the category of 'vulnerable newborns' because of the large proportion of total perinatal morbidity and mortality. Th ey are especially susceptible to oxidative stress, which aff ects a variety of organs, often simultaneously, causing neonatal diseases such as retinopathy of prematurity (ROP), bronchopulmonary dysplasia, necrotizing enterocolitis, intraventricular hemorrhage, periventricular leukomalacia, respiratory distress syndrome, intrauterine growth retardation and congenital malformation. Th ese diseases have also been reported to be oxidative stressrelated neonatal diseases 1, 2 . Retinopathy of prematurity (ROP) is the most important disease of prematurity and a major cause of blindness in children. ROP continues to be the leading cause of lifelong visual impairment among children in developed countries 3 . ROP occurs in two phases. Th e ischemic phase 1 begins after premature birth with delayed retinal vascular growth. Th e proliferative phase 2, characterized by pathologic neovascularization, occurs around 33 rd postmenstrual week (pmw) [4] [5] [6] [7] [8] . Oxidative stress is imbalance between the production of pro-oxidants and the ability of the body to detoxify their harmful eff ects through neutralization by antioxidants. Th e process of birth itself is an oxidative challenge for the newborn. Sharp postnatal transition from intrauterine environment with a relatively low oxygen content into an environment with signifi cantly higher oxygen content exposes the infant to oxidative stress, which is emphasized in premature infants due to low effi ciency of antioxidant protection 9 . In premature infants, autoregulation of the blood network of retina is adequate in a narrow range of perfusion pressure. Th e absence of autoregulation leads to hyperoxia of retina 10 . Disturbance in the equilibrium of pro-oxidants and antioxidants initiates an infl ammatory process in retinal tissue leading to development of ROP 11, 12 . Free radicals are reactive and short-lived species so that direct measurement is usually not possible. However, hundreds of reactive oxygen species are known to be derived from the interaction of free radicals with biomolecules 1 . Alternatively to measurements of oxidation products, a test measuring total oxidative status (TOS) was recently developed 13 . Malondialdehyde (MDA) is the end product of lipid peroxidation and a good marker of oxidative stress. Th is aldehyde is a highly toxic molecule. Its interaction with DNA and proteins has often been referred to as potentially mutagenic and atherogenic 12, 14, 15 . Total antioxidant status (TAS) is not just a simple sum of the individual activities of antioxidant substances. It is actually a dynamic system of interdependent individual serum antioxidant parameters. TAS assay has been designed to determine the overall antioxidant power of samples contributed by antioxidants and their interactions. Evaluation of TAS in body fl uid has been used as one of the biological markers for monitoring oxidative stress in humans 16 . Paraoxonase (PON) is a Ca 2+ -dependent enzyme that is synthesized in the liver and is found in various tissues and plasma. Th e enzyme takes place in the structure of high-density lipoprotein (HDL) in plasma 17 . PON1 has antioxidant property because it prevents the increase of reactive oxygen species quantity by hydrolyzing lipid peroxidation products. It also protects cell from damage caused by oxidative stress 18 . PON family members were upregulated in late-gestation human fetuses and are a candidate therapeutic in premature human infants 19 . Studies have confi rmed that oxidative stress leads to tissue damage during pregnancy, and clinical practice has confi rmed that the application of antioxidants can prevent and reduce the diseases caused by oxidative stress [20] [21] [22] . Th e purpose of our study was to evaluate and compare the pro-oxidant/antioxidant status in preterm infants (with and without ROP) at 33 rd pmw (the beginning of phase 2 ROP) by measuring the TOS, MDA, TAS and PON1 activity.
Materials and Methods

Study design and patients
Th e study (cohort, prospective) was conducted in the Department of Neonatology, Clinical Centre of Montenegro, Podgorica, with parental informed written consent and after institutional ethical clearance. Th e study included 59 premature infants, gestational age (GA) of 33 weeks or less. Venous blood sample was obtained from every infant included in the study in the 33 rd pmw. All parameters were determined at 33 rd pmw. Preterm neonates with gross congenital abnormalities were excluded from the study.
Screening for ROP was done by indirect ophthalmoscopy. ROP was classifi ed according to the International Classifi cation (ICROP) and subdivided into 5 stages. Proliferative ROP (ROP+) was defi ned as stage 3, stage 4 or stage 5. Th ese infants required treatment for ROP (laser therapy or anti-VEGF treatment). Infants with correct ophthalmologic fi ndings and moderate ROP (stage 1 and stage 2) were defi ned as infants without ROP (ROP-).
Ethics Committee of the Clinical Centre of Montenegro in Podgorica approved the study protocol (consent number 03/01-3813/4), in accordance with standard procedures of the Ethics Committee of the Clinical Center of Montenegro and international guidelines for the performance of biomedical research on humans.
Measurement of pro-oxidant markers
Since the measurement of diff erent oxidant molecules separately is not practical, TOS of a sample was measured. We used Erel's colorimetric method for measuring TOS. Th e assay is based on the oxidation of ferrous ion to ferric ion. Color intensity, which can be measured spectrophotometrically, is related to the total amount of oxidant molecules present in the sample. Th e assay is calibrated with hydrogen peroxide (H 2 O 2 ) and the results were expressed in terms of micromolar hydrogen peroxide equivalent per liter (μmol H 2 O 2 Eq/L) 13 . MDA was determined as a thiobarbituric acid-reacting substance (TBARS) spectrophotometrically. Th iobarbituric acid (TBA) is widely used to measure TBARS of lipid oxidation. TBA reacts with MDA, a product of lipid oxidation, to give a red, fl uorescent MDA/TBA adducts with maximum absorbance at 532 nm. Th e results are expressed in μmol/L 15 .
Measurement of antioxidant markers
Total antioxidant status assays have been designed to determine overall antioxidant power of samples. TAS was determined by a modifi ed Erel's method, i.e. a colorimetric test which depends on the production of hydroxyl radical. Th e results are expressed in mmol/L 23 . We used the principle of spectrophotometric determination of PON1 activity by using paraoxon as substrate. Th e sample is mixed with a substrate dissolved in a buff er solution, and the product generated by hydrolysis of the substrate is monitored for a certain time at a linear rate and defi ned temperature. Th e results are expressed in U/L 24 .
Statistical analysis
Data were presented as mean ± standard deviation (SD). Kolmogorov-Smirnov test was used to verify the normality of distribution of parameters. In order to analyze statistically signifi cant diff erences in the mean values of the examined parameters between the groups, Student's t test was used according to data distribution. Th e existence of statistically signifi cant correlations between variables was confi rmed using the Spearman nonparametric correlation. A p-value of less than 0.05 was considered statistically signifi cant.
Results
Overall, 59 patients were included in the study. ROP was diagnosed in 18 (30.5%) infants, whereas in 41 (69.5%) infants ophthalmologic fi ndings were correct or they had moderate ROP.
Th e mean gestational age (GA) and birth weight (BW) of preterm infants with and without ROP are displayed in Table 1 . Student's t-test showed significant diff erence in GA and BW between infants with and without ROP. Premature infants with ROP had a signifi cantly shorter mean GA (p<0.01) and lower mean BW (p<0.05).
Th e mean length of mechanical ventilation for infants with ROP was 14.1±1.31 days. Th e mean length of mechanical ventilation for infants without ROP was 6.1±0.54 days (Fig. 1 ). Student's t-test showed a statistically signifi cant diff erence in the length of ventilation for infants with and without ROP. Premature infants with ROP were ventilated signifi cantly longer (p<0.05).
Th e values of the pro-oxidant and antioxidant markers are presented in Table 2 . TOS and MDA values in premature infants with ROP were TOS 60.6±4.88 μmol/L and MDA 1.82 (1.38 to 2.40) μmol/L. In premature infants without ROP, the prooxidant markers were lower: TOS 38.6±3.17 μmol/L and MDA 1.33 (1.16 to 1.52) μmol/L. For both parameters, the diff erence was statistically signifi cant (p<0.05).
Premature infants that developed ROP had lower values of TAS (1.1±0.64 mmol/L) than infants without ROP (1.2±0.69 mmol/L). PON1 activity was higher in infants with ROP (89.6±13.0 U/L) than in (Table 3) . We also found signifi cant positive correlation between PON1 activity and MDA (Table 3) .
Discussion and Conclusion
Newborns, especially premature ones, are at an increased risk of damage mediated by oxidative stress. In the present study, we investigated parameters of oxidative stress (pro-oxidants and antioxidants) in premature infants at 33 rd pmw (onset of ROP 2 phase) in order to understand the signifi cance of these parameters in the pathogenesis of ROP.
Pro-oxidants were assessed by measuring TOS and serum MDA. Antioxidant protection was estimated by measuring TAS and PON1 activity. Nowadays, these markers can be measured by simple and sensitive methods.
All infants included in the study (N=59) were screened for ROP. Timing of the fi rst ROP screening examination was also at 33 rd pmw. Laser photocoagulation was used in 18 (30.5%) infants.
According to our results, premature infants with ROP had a signifi cantly lower BW, shorter GA (Table  1 ) and longer duration of mechanical ventilation (prolonged oxygen exposure) (Fig. 1) .
Studies also confi rmed strong connection between short GA, low BW, mechanical ventilation and ROP. It has been reported that premature infants on prolonged ventilation have more chances for development of ROP 12, 25, 26 . We found a statistically signifi cant diff erence in TOS values between infants with and without ROP. Infants with ROP had signifi cantly higher values of TOS (Table 2) .
Studies confi rm that vasoconstriction in the retina is an early response to oxygen that can lead to vasoobliteration, neovascularization, and retinal traction (ROP). Disturbance in the equilibrium of oxidant and antioxidant status initiates an infl ammatory process in retinal tissue leading to development of ROP 12, 27 . As shown in Table 2 , MDA was also signifi cantly higher in infants with ROP. According to our results, serum concentration of MDA is a good marker of oxidative stress and a ROP predictor.
Studies have shown that elevated levels of serum MDA were associated with adverse respiratory and ophthalmologic outcome in very-low-birth-weight infants 14 . Infants exposed to higher oxidative stress (premature infants, newborns from cesarean section) have a higher level of MDA 28, 29 . Also, signifi cant oxidative stress can be easily assessed by measuring urinary MDA levels 30 . Th e concentrations of MDA were not predictors of bronchopulmonary dysplasia/death 31 . In the present study, we did not fi nd a statistically signifi cant diff erence in TAS values and PON1 activity between the groups. TAS values were lower in infants with ROP, while the values of PON1 activity were even higher in infants with ROP (Table 2) .
Studies confi rm that inadequate TAS is associated with development of various pathologic conditions including hypoxic injury and ROP 32 . Decreased maternal serum PON1 levels may also have a role in preterm 33 . Th ere are a limited number of studies on preterm infants, which evaluated PON1 levels, especially in infants with ROP.
Our results showed positive correlation between MDA and PON1 (Table 3) , which made us think of the possible compensatory increase in PON1 as a protective factor. PON1 plays an important role as an antioxidant in preventing oxidation of low-density lipoproteins 34 . Our study showed the level of oxidants to correlate signifi cantly with the development of ROP. Our results did not confi rm statistically signifi cant betweengroup diff erence in the level of antioxidants. We suppose that the reason for the increased levels of antioxidants at 33 rd pmw in infants with ROP was in response to oxidative stress.
According to our results, TOS and MDA are good markers of oxidative stress, while TAS and PON1 activity are unreliable in assessing antioxidant protection.
Additional research in this area should contribute to better understanding the pathogenesis of ROP, as well as to development of more eff ective preventive and therapeutic procedures.
